Private Advisor Group LLC lessened its holdings in Vanguard Russell 1000 (NASDAQ:VONE – Free Report) by 8.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,897 shares of the company’s stock after selling 178 shares during the quarter. Private Advisor Group LLC’s holdings in Vanguard Russell 1000 were worth $493,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Peoples Bank KS acquired a new stake in Vanguard Russell 1000 in the third quarter worth about $34,000. Geneos Wealth Management Inc. acquired a new stake in shares of Vanguard Russell 1000 during the first quarter worth about $35,000. Ashton Thomas Private Wealth LLC acquired a new stake in shares of Vanguard Russell 1000 during the second quarter worth about $143,000. Valmark Advisers Inc. acquired a new stake in shares of Vanguard Russell 1000 during the second quarter worth about $239,000. Finally, Moser Wealth Advisors LLC acquired a new stake in shares of Vanguard Russell 1000 during the second quarter worth about $246,000.
Vanguard Russell 1000 Stock Down 0.2 %
Vanguard Russell 1000 stock opened at $258.77 on Tuesday. Vanguard Russell 1000 has a 52 week low of $196.58 and a 52 week high of $265.76. The company has a market capitalization of $5.14 billion, a price-to-earnings ratio of 24.78 and a beta of 1.02. The stock has a 50-day moving average price of $258.02 and a 200 day moving average price of $248.39.
Vanguard Russell 1000 Increases Dividend
Vanguard Russell 1000 Profile
The Vanguard Russell 1000 ETF (VONE) is an exchange-traded fund that is based on the Russell 1000 index, a market-cap-weighted index of the 1000 largest US companies. VONE was launched on Sep 20, 2010 and is managed by Vanguard.
Further Reading
- Five stocks we like better than Vanguard Russell 1000
- Upcoming IPO Stock Lockup Period, Explained
- Intel: Is Now the Time to Be Brave?Â
- Stock Analyst Ratings and Canadian Analyst Ratings
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Compound Interest and Why It Matters When Investing
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Vanguard Russell 1000 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Russell 1000 and related companies with MarketBeat.com's FREE daily email newsletter.